Michael Cahn, PA
Surgery · Shallotte, NCNPI 1215005459
Payments from drug & device makers
What this record shows
This record is dominated by other: $20,960 of the $26,472 with a category attached, or 79.2%. Angiodynamics, Inc. accounts for 98.2% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $6,594, more than ten times the $384 reported in 2019. Among surgery clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 23 payments — averaging $1150.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$26K
- Boston Scientific$199
- Medtronic$185
- Davol Inc.$20
- Organogenesis Inc.$19
- Teva Pharmaceuticals USA, Inc.$17
- plus $26 from 2 others
What the payments were for
- Travel & lodging$190%
- Food & beverage$6332%
- Education$4,86018%
- Other$20,96079%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 13 | $26,006 |
| Boston Scientific | 3 | $199 |
| Medtronic | 2 | $185 |
| Davol Inc. | 1 | $20 |
| Organogenesis Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Biowound Solutions, Inc. | 1 | $14 |
| Cashflow Solutions, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaCure 1470 Pro$25,427
- VenaSeal$177
- SPECTRA WAVEWRITER$106
How this compares
$26,472 in reported general payments places this provider in the 90th percentile of 970 surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 22 | $240 |
| Cephalexin | 204 | $216 |
| Alprazolam | 215 | $165 |
| Tramadol Hcl | 194 | $142 |
| Ciprofloxacin Hcl | 42 | $77 |
Paid to pharmacies, not to this prescriber.
Other surgery in Shallotte
- Brant HenifordCharlotte$831K
- Vedra AugensteinCharlotte$789K
- John MartinieCharlotte$712K
- Dana PortenierDurham$702K
- Paul EnochsCary$595K
- David IannittiCharlotte$360K
- William HopeWilmington$350K
- Martyn KnowlesRaleigh$311K
- Walter BoydGreenville$311K
- Gregory StanleyCharlotte$304K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.